Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Astra Merck

Executive Summary

Astra Merck: Nancy Wysenski to VP-sales and Barry Greene to VP-marketing and customer services, filling roles vacated by VP-Sales and Marketing Matthew Emmens. Emmens was named acting CEO Jan. 17, replacing Wayne Yetter, who departed to lead Novartis' U.S. pharmaceuticals business ("The Pink Sheet" Feb. 3, T&G-1). Wysenski was executive director of field sales at Astra Merck; Greene had worked on process design for Astra Merck's sales and marketing organization as an associate partner with Andersen Consulting. Astra Merck also announces the promotions of VP-Drug Development Irwin Scher to chief medical officer and senior VP-drug development; VP-Portfolio Management Dave Brennan to senior VP-business operations; and Rob Cohen, VP-information technology, to chief information officer...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029715

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel